Wockhardt’s Molecule Drives 5x Stock Increase in a Year: 25 Years of Research Pays Off
The pharmaceutical industry is no stranger to long-term investments in research and development (R&D). One of India’s prominent pharmaceutical companies, Wockhardt, witnessed an unprecedented stock surge, climbing fivefold due to the success of a unique molecule developed over 25 years.










